Medical Marijuana, Inc. is the first publicly held company vested in the industrial hemp and legal cannabis industries. It is a company made up of a diversified portfolio of products, services, business, and technology focused completely on the production of high concentrate hemp oil products that are rich in cannabinoid. Medical Marijuana, Inc. trades in the OTC market under the symbol MJNA.
Medical Marijuana, Inc. aims to be the premier innovator in the hemp and cannabis industry, leveraging its team of professionals into sourcing, evaluating, and purchasing value-added products and companies. It strives to do so while simultaneously allowing them to keep their entrepreneurial spirit and integrity. The company also commits to create awareness within the industry, and develop environmentally friendly and economically stable businesses while increasing the value of their shareholders.
Medical Marijuana, Inc.’s range of products stem anywhere from proprietary and patented cannabinoid-based products to seed and stalk or unique high value extracts that are purposely formulated and manufactured for the cosmetics, nutraceutical, pharmaceutical, and food industries.
The company offers a varied and extensive selection of services, such as medical clinic management, development of existing industry business and product leaders, development of medical grade compounds, and development of cannabinoid-based health and wellness products. At present, Medical Marijuana, Inc. provides more than 80 proprietary and patent pending cannabinoid delivery methods, which are deemed more medically and socially acceptable compared to the usual industry methods.
Other services offered by Medical Marijuana, Inc. include licensing of its proprietary testing, labeling, genetics, packaging, production, tracking, and standardization of methods for the medicinal herb industry.
Medical Marijuana, Inc.’s portfolio companies include Canipa Holdings, Red Dice Holdings, Wellness Managed Services, HempMeds PX, KannaLife Sciences, Phytosphere, and CanChew Gum. Whether wholly owned or partially owned, all these businesses are integral part of Medical Marijuana, Inc. Featured products of these companies are Cibdex, Cibaderm, Dixie Botanicals, and Real Scientific Hemp Oil.
Yahoo! Finance: MJNA News
Latest Financial News for MJNA
SAN DIEGO , March 18, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that its subsidiary HempMeds® Brasil ...
SAN DIEGO, March 14, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that an op-ed article written by the company's CEO Dr. Stuart Titus was published in the prestigious regional news publication, The San Diego Union-Tribune. "It's an honor to be featured in this publication and help consumers understand that hemp and CBD are not just a fad, they're here to stay," said Titus. In addition to explaining how international regulatory bodies, such as the World Health Organization, have stated that CBD is "is not harmful, has health benefits, and does not have abuse potential," the article outlines an analysis by The Brightfield Group that positions the market for hemp-derived CBD products, which was about $591 million in 2018, to grow to $22 billion by 2022.
SAN DIEGO, March 13, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former Kansas City Chiefs Offensive Lineman John Alt has joined as their newest spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "We are excited that John as seen great results on our Revive, Kannaway Gold and Kannaway Premium Full-Spectrum products," said Kannaway® CEO Blake Schroeder.
SAN DIEGO, March 8, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® has launched its newest cannabidiol (CBD) Personal Care Line in celebration of International Women's Day. According to a new report by Eaze, an online marketplace and technology platform for legal cannabis, the number of women buying cannabis products almost doubled in 2018, increasing by 92 percent. Women now make up 38 percent of all cannabis consumers.
SAN DIEGO, March 6, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that they have welcomed former Miami Dolphins Linebacker Bruce Bannon as their newest spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers. "We're thrilled that Bruce is taking our Pure Gold and Premium Full Spectrum CBD products and we hope that he continues to find success using them," said Kannaway® CEO Blake Schroeder.